Catalyze: Product Definition for Small Molecules and Biologics - Preliminary Product/Lead Series Identification (R33 - Clinical Trial Not Allowed)
Key Information
Due Date: December 20, 2024
Agency: U.S. Department of Health and Human Services (HHS)
Source: Federal
Funding Category:
Health & Human Services
Funding Amount: $581,371
Funding Type: Grant
Match Required: No
Status: Posted
Contact Info:
OERWebmaster03@od.nih.gov
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Overview
This FOA is just one part of the larger Catalyze innovation grants, which are focused on advancing projects until they reach a point where they're ready for the NHLBI Catalyze Preclinical program. Alternatively, these projects could also attract independent support from other federal entities or private partners. This support would aid in the preclinical stage of optimization and further development of therapeutic agents.
Key Dates
Open Date: January 24, 2022
Application Due Date: December 20, 2024
Estimated Award Date: Not Specified
Additional Details
Eligible Activities
- Research and Development
Eligible Applicants
- State governments
- County governments
- City, village or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Private institutions of higher education
- Small businesses